Variation in the expression levels of predictive chemotherapy biomarkers in histological subtypes of lung adenocarcinoma: an immunohistochemical study of tissue samples

about

Variation in the expression levels of predictive chemotherapy biomarkers in histological subtypes of lung adenocarcinoma: an immunohistochemical study of tissue samples

Item

http://www.wikidata.org/entity/Q36261427

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Variation in the expression le ...... emical study of tissue samples

@ast

Variation in the expression le ...... emical study of tissue samples

@en

type

Item

label

Variation in the expression le ...... emical study of tissue samples

@ast

Variation in the expression le ...... emical study of tissue samples

@en

prefLabel

Variation in the expression le ...... emical study of tissue samples

@ast

Variation in the expression le ...... emical study of tissue samples

@en

P1476

Variation in the expression le ...... emical study of tissue samples

@en

P2093

Kazue Shimizu

http://www.w3.org/2001/XMLSchema#string

Kazuhisa Takahashi

http://www.w3.org/2001/XMLSchema#string

Kazuya Takamochi

http://www.w3.org/2001/XMLSchema#string

Kenji Suzuki

http://www.w3.org/2001/XMLSchema#string

Miniwan Tulafu

http://www.w3.org/2001/XMLSchema#string

Shiaki Oh

http://www.w3.org/2001/XMLSchema#string

Shinsaku Togo

http://www.w3.org/2001/XMLSchema#string

Takuo Hayashi

http://www.w3.org/2001/XMLSchema#string

Toshimasa Uekusa

http://www.w3.org/2001/XMLSchema#string

Yuichi Fujimoto

http://www.w3.org/2001/XMLSchema#string

P2860

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysis.

RRM1 expression and clinical outcome of gemcitabine-containing chemotherapy for advanced non-small-cell lung cancer: a meta-analysis.

Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung

Association between TYMS expression and efficacy of pemetrexed-based chemotherapy in advanced non-small cell lung cancer: a meta-analysis.

Targeted therapy in combination with gemcitabine in non-small cell lung cancer.

Clinical application of biological markers for treatments of resectable non-small-cell lung cancers.

P304

10523-10533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26617762

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

biomarker

immunohistochemistry

P932

4637577

http://www.w3.org/2001/XMLSchema#string